Philips
(NYSE: PHG)
announced today that the FDA granted 510(k) clearance for its Zenition 30 mobile C-arm.
Zenition 30 reduces the dependency on support personnel by giving surgeons greater flexibility, control and personalization of C-arm movement and user settings. This can help to alleviate staff shortages that limit patient access and increase waiting times. It could also address budgetary constraints that affect today’s hospital systems.
With enhanced workflow efficiency through C-arm control alongside the patient table, surgeons can treat more patients. All the while, they can spend more time focusing on each patient, leading to a better patient and staff experience.
Zenition 30 features Philips’ latest-generation flat detector technology, advanced imaging algorithms and personalized user profiles. It delivers superior image quality, coupled with dose settings and a way of working from the moment users logo on. Fewer manual adjustments can lead to smoother procedures and more first-time-right imaging.
Additionally, Philips designed it with the BodySmart software feature to enhance image capture without manual adjustments. Surgeons can also select from a range of application-specific protocols for different types of surgeries. For patients with metal implants, Philips MetalSmart software automatically adjusts image contrast and brightness. This improves image quality and eliminates blooming while maintaining a low X-ray dose.
Zenition 30 also offers digital subtraction angiography (DSA), allowing for clear imaging of vasculatures. It features an electromagnetic braking system on either side of the C-arm stand, too. This eliminates the manual effort required for technicians to release and apply conventional mechanical brakes.
“Based on our Zenition platform’s proven ease of use and workflow efficiency, the new Zenition 30 offers a unique combination of personalized control and image clarity to enhance the speed and accuracy of decision making for a range of clinical procedures at a price point that meets today’s economic and business goals,” said Mark Stoffels, GM, Philips Image-Guided Therapy Systems.